ArticleClinical drug investigation2022
Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression.
Juliana Surjan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it